Prostate Cancer News

January 9, 2017

Webcast: Reducing Prostate Cancer Radiation Treatment Complications – 6pm EST

Dr. Paul Nguyen to present a podcast on January 11, 2017 at 6:00pm EST. Get more information and watch it on Prostate Health Education Network.
December 21, 2016

Augmenix To Present at the 35th Annual J.P. Morgan Healthcare Conference

Augmenix, Inc. will participate in the 35th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. John Pedersen, Chief Executive Officer, is scheduled to present on Thursday, January 12, 2017 at 9:30 a.m. Pacific Time in the Elizabethan D room.
November 17, 2016

Augmenix to Present at the Annual Piper Jaffray Healthcare Conference on Wednesday, November 30

Augmenix, Inc. today announced that it will present at the Piper Jaffray 28th Annual Healthcare Conference at the Lotte New York Palace Hotel in New York City on Wednesday, November 30, 2016. John Pedersen, Chief Executive Officer is scheduled to present at 1:10 p.m. Eastern Time.
November 13, 2016

Current clinical trials at UTSW are implementing SpaceOAR hydrogel in order to reduce the side effects associated with SBRT

UT Southwestern served as the lead site for a multi-institutional five-year clinical trial, which revealed that Stereotactic Body Radiation Therapy (SBRT) offers a higher cure rate for prostate cancer patients than more traditional approaches.
July 27, 2016

Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA

The effect of lycopene-containing foods in prostate cancer development remains undetermined. We tested whether a lycopene-rich tomato intervention could reduce the levels of prostate specific antigen (PSA) in prostate cancer patients.
July 26, 2016

PSA Screening: Don’t Throw the Baby Out With the Bathwater

Population-based prostate cancer screening remains decidedly controversial, especially after the US Preventive Services Task Force (USPSTF) recommended against routine prostate-specific antigen (PSA)-based prostate cancer screening for healthy men in 2012, regardless of age. But prostate cancer experts have maintained that PSA testing is useful and that it reduces the risk for death — and this argument is made forcefully in a Comments paper published online July 18 in the Journal of Clinical Oncology (JCO).
July 20, 2016

Metastatic Prostate Cancer Needs Genetic Testing; Here’s Why

Germline genetic testing should be offered to men with metastatic prostate cancer, regardless of age or family history, say the authors of a new study.
July 20, 2016

Introducing SpaceOAR®: the newest tool in the fight against prostate cancer – Available only at St. Mary’s Regional Cancer Center

St. Mary’s Regional Cancer Center is helping to pioneer a new tool proved to protect prostate cancer patients from the negative effects of radiation therapy. Patients at St. Mary’s are now being injected with SpaceOAR® hydrogel, the first FDA-cleared spacing device to protect the rectum in men undergoing radiation therapy for prostate cancer. The SpaceOAR System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer, creating space to protect the rectum from radiation exposure.
July 18, 2016

Right Dose per Fraction Key in Prostate Cancer Radiotherapy

Two trials comparing hypofractionated radiation with conventional radiation for localized prostate cancer have come to opposite conclusions. But the two studies used different schedules of hypofractionation, and it is the dose per fraction that is important, says an expert not involved in either study.
July 15, 2016

Can a man be too young for active surveillance?

There is a “conventional wisdom” that active surveillance (AS) is only for older men, and that younger men are better off having immediate radical treatment, typically prostatectomy (RP). By “better off” we mean that there is a better chance at cancer control, or that the side effects of treatment, particularly incontinence and impotence, will be milder if treated earlier.
July 14, 2016

Statin Treatment Linked to Fewer Cancer Deaths

Being treated for high cholesterol with statins is being linked with a reduced risk of death and better survival from four common cancers, a medical conference has heard.
July 13, 2016

Refining knowledge about familial risk for prostate cancer

We have known for years that if your father or your brother is diagnosed with prostate cancer, it affects your own risk for prostate cancer … but what sorts of prostate cancer are we talking about? Aggressive, indolent, metastatic, localized, what?
July 13, 2016

Augmenix Financing Will Enable Sales Growth

Augmenix, Inc., a privately held company developing minimally invasive hydrogel products to improve outcomes following cancer radiotherapy, today announced it secured $6 million in series E funding from existing investors. This infusion of capital will allow Augmenix to focus on next-generation products and build on significant growth driven by the robust commercial uptake of its innovative SpaceOAR® System.
June 16, 2016

Local Therapy Benefits Some Metastatic PCa Patients

Local therapy (LT) may offer a survival advantage to men diagnosed with metastatic prostate cancer (mPCa) who have specific characteristics, according to a new study.
June 15, 2016

Factors Affecting Post-Brachytherapy Urinary Incontinence Type ID’d

Urinary incontinence (UI) develops in a small percentage of patients with localized prostate cancer (PCa) treated with brachytherapy, a new study confirms.
June 14, 2016


A recent study funded by the Prostate Cancer Foundation (PCF) reports a new strategy for "fine-tuning" how the body processes abiraterone to optimize therapy for men with metastatic, treatment-resistant prostate cancer (mCRPC).
June 13, 2016

Prostate Cancer: New Directions With Active Surveillance

Howard Wolinsky, a journalist based in the Chicago area, was diagnosed with early prostate cancer in 2010. This is the latest in a series of articles in which he shares his experience with active surveillance and his ongoing quest to make the best -- and most informed -- decision about his care.
June 10, 2016

Coping with active surveillance anxiety in prostate cancer

Men with prostate cancer who are under medical surveillance reported significantly greater resilience and less anxiety after receiving an intervention of mindfulness meditation, a study found.
June 9, 2016

Imaging biomarker distinguishes prostate cancer tumor grade

Physicians have long used MRI to detect cancer, but results of a new study describe the potential use of RSI as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.
June 8, 2016

mpMRI scans can eliminate the need for prostate biopsy in 27 percent of men at risk

The PROMIS trial was a prospective, paired-cohort confirmatory study, designed to provide level 1b evidence of the value of multi-parametric MRI (mpMRI) scanning as a test to see whether some men at hypothetical risk for prostate cancer could avoid the need for prostate biopsy altogether.
June 7, 2016

Higher BMI, waist circumference are associated with increased risk of aggressive prostate cancer

A study of almost 150,000 men from 8 European countries, presented at this year's European Obesity Summit (Gothenburg, 1-4 June) shows that higher BMI and waist circumference are associated with an increased risk of aggressive prostate cancer.
May 26, 2016

Prostate Cancer Treatment Evolves

More men with low-risk prostate cancer are choosing active surveillance—a trend that suggests that skepticism about delaying immediate treatment is diminishing.
May 25, 2016

Sexual Function After Prostate Cancer Surgery: What You Should Know

Even an expertly performed nerve-sparing radical prostatectomy causes some degree of trauma to nerve bundles. Below are some important facts about sexual function and what to expect after robotic-assisted or traditional open radical prostatectomy..
May 24, 2016

Age, Race, Family History and Prostate Cancer: The Basics

The underlying cause of prostate cancer is unknown. As with other cancers, however, multiple events over a period of many years are probably necessary to produce a cancerous change in a prostate cell.
May 23, 2016

What NOT to Do Before Your PSA Test

Did you know... Having sex within 72 hours of your PSA test can produce a false reading? ED can be a symptom of prostate cancer? By age 70, the average man's prostate has doubled in size.
May 20, 2016

What You Need to Know About Vitamin E, Selenium and Prostate Cancer

Both vitamin E and the mineral selenium have long been under study for their potential to prevent or slow the progression of prostate cancer.
May 17, 2016

Science Daily – Quality of life meets cure for prostate cancer treatment

A new paper looks at how MRI and a clear understanding of the functional anatomy around the prostate can allow radiation oncologists to plan a course of treatment for patients with prostate cancer that spares these critical structures.
May 16, 2016

Newsmax – Symptoms of Prostate Cancer You Might Not Know About

Common symptoms of prostate cancer are associated with the urinary system, but other lesser-known symptoms may affect other areas of the body if the cancer cells begin to spread.
Have you told your friends that you love your electricity provider? At Gexa, you'll be rewarded for that recommendation.
May 15, 2016

Medpage Today – Adjuvant Chemo in the Mix for High-Risk Prostate Cancer?

Men with high-risk prostate cancer had a 10-month improvement in progression-free survival (PFS) with adjuvant chemotherapy...
Augmenix SpaceOAR Resource Library
May 14, 2016

Medscape – Prostate Cancer: ‘Active’ Surveillance Is Often ‘Not’

Under active surveillance, both patients and providers "may have a tendency to get a little lackadaisical,"
May 13, 2016

Prostate Cancer Risk Not Increased With Testosterone Therapy

Testosterone treatment is not associated with an increased likelihood of being diagnosed with prostate cancer (PCa).
May 11, 2016

Renal and Urology News – Higher Radiation Dose Key to Better Brachytherapy Outcomes

Higher radiation doses are critical to optimizing long-term outcomes following brachytherapy for prostate cancer, a study presented at AUA 2016 suggests.
May 10, 2016

Medical News Today – Prostate cancer: Testosterone therapy ‘does not increase aggressive disease risk’

Men prescribed testosterone replacement therapy (TRT) for longer than a year showed no overall increase in risk of developing prostate cancer...
May 9, 2016

Medscape – African-American Men Experience More Aggressive Prostate Cancer

One reason for these disparities might relate to differences in mitochondrial function.
Have you told your friends that you love your electricity provider? At Gexa, you'll be rewarded for that recommendation.
May 7, 2016

Medpage Today – Seeking Meaning in Cancer Survival Risk Estimates

By searching the Internet on their own, fewer than 20% of 140 study participants came within 10 percentage points of a hypothetical patient's likely 15-year cancer-specific survival.
May 6, 2016 – Natural History of Prostate Cancer if Left Untreated

While most men undergo some form of treatment for their prostate cancer, some men today choose to not be treated for their prostate cancer.
May 6, 2016

Medscape – New FDA-Approved HIFU Ultrasound for Prostate Health

Since the approval of two high-intensity focused ultrasound (HIFU) devices last fall by the US Food and Drug Administration (FDA), the field of urology in the United States has been in limbo.
May 5, 2016

Renal & Urology News – The Psychological Impact of Prostate Cancer

Cancer may or may not be life ending, but it is almost certainly life changing.
May 5, 2016

PCTRF – Reduce Prostate Cancer Radiation Side Effects

Richard Hsi, MD, Medical Oncologist describes a breakthrough method to reduce side effects when prostate cancer is treated with radiation.
May 4, 2016

Medscape – USPSTF Re-evaluates PSA Testing; Here’s Their Plan

Dr Hoffman is concerned that "abandoning PSA screening" is proving harmful.
May 3, 2016

Medical News Today – A new class of drug attacks cancer indirectly by destabilizing proteins

"These drugs can hit cancer harder than those targeting only one protein and look promising for preventing or overcoming drug resistance."
May 2, 2016

Medscape – No Worries: PSA ‘Bounce’ With Prostate Cancer Tied to Sex

A small rise and fall in PSA level after curative radiation therapy for prostate cancer is more common in men who are more sexually active, according to a study from Japan.
April 30, 2016

Prostate Cancer Foundation Announces New Chief Operating Officer John H. Weston

"We know John with his extensive leadership credentials in healthcare and medical research will make very valuable contributions to PCF's future initiatives which will bring precision medicine to every man diagnosed with prostate cancer."
April 29, 2016

Prostate Cancer Foundation – Sugary Drinks, ‘Bad’ Carbs Tied to Breast, Prostate Cancers

People who consume a lot of processed carbohydrates -- think snack foods and sweets -- and sugary drinks may face heightened risks of breast and prostate cancers, a new study suggests.
April 28, 2016

Renal and Urology News – Simpler Prostate Cancer Grading System Proposed

A consensus panel of experts has proposed a new and simpler prostate cancer grading system that could help clinicians give patients a better understanding of their prognosis.
Prostate cancer: Diagnosing, grading and staging
April 27, 2016

Prostate Cancer Infolink – Active surveillance studies can have highly informative results — even when poorly executed!

The results are actually astonishingly good for both the very low-risk and the low-risk subsets of patients, and they aren’t terrible for the intermediate-risk patients
April 26, 2016

Prostate Cancer Foundation – New Genetic Test Helps To Select Best Medicines For Prostate Cancer Treatment and Identifies Hereditary Cancer Genes

"This is a clinical test that we can do in real time for patients. The results come back in 4-6 weeks, so it is feasible to identify clinically actionable mutations..."
April 25, 2016 – What NOT to Do Before Your PSA Test

Early detection of prostate cancer is a KEY factor in treating this disease successfully. Being fully informed is also important -- and that's where the 2016 Prostate Disorders White Paper comes in.
April 24, 2016

Renal & Urology News – Saturation Prostate Biopsy Not Better

Saturation prostate biopsy does not increase the likelihood of detecting high Gleason grade tumors, according to a new study.
April 23, 2016

Prostate Cancer Infolink – The incidence of prostate cancer in Africa

...we know that the risk for prostate cancer among men of African ancestry in the Caribbean and in the Americas is much higher that that of men of European ancestry.
Internal beam radiation therapy: Treatment options for prostate cancer
April 22, 2016

MedScape – Urologists Should Disclose Prostatectomy Volume, Experience

All too often, patients may be reluctant to question their doctors about their proficiency. I'd like to suggest that, as part of the consent process, urologists have an obligation to provide that information even if patients don't ask them.
April 22, 2016

Prostate Cancer Foundation – Regular Exercise May Boost Prostate Cancer Survival

Sticking to a moderate or intense exercise regimen may improve a man's odds of surviving prostate cancer.
April 21, 2016

MedScape – 3% of Surveillance Cohort Has Metastatic Prostate Cancer

"We took an inclusive approach to active surveillance, and more than 20% of our cohort was at intermediate risk."
April 21, 2016 – Obesity May Boost Prostate Cancer Risk in African-Americans

Both African-American and white men with a BMI of 35 or higher were more likely to have high-grade cancer than men with a BMI of 25 or lower.
April 20, 2016

Medscape – Fewer Smokers, Fewer Prostate Cancer Deaths

"Finally, these findings support population-wide reductions in smoking as a potential strategy to reduce deaths from prostate cancer,"
April 20, 2016

MedPage Today – Combo Tx Slows Prostate Cancer Relapse

Men with hormone-sensitive prostate cancer had a significantly longer relapse-free interval with the addition of bevacizumab (Avastin) to short-course androgen deprivation therapy (ADT)...
April 20, 2016

Prostate Cancer Infolink – Saturated fats and prostate cancer risk — again

Data from the North Carolina-Louisiana Prostate Cancer Project ... have again shown that diets high in saturated fats seem to increase risk for aggressive forms of prostate cancer.
April 19, 2016

MedScape – Depression Yet Another Side Effect of ADT?

Androgen deprivation therapy (ADT) may be linked to depression in older men with localized prostate cancer.
April 19, 2016

Science Daily – 98 percent cure rate for prostate cancer using stereotactic body radiation therapy, research shows

A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches
April 18, 2016

Prostate Cancer Infolink – Better cancer control with radiation vs. surgery in high-risk patients

While the researchers did not report on toxicities, it is safe to say that those who received original RP suffered worse toxicities.
Spending more time outdoors and away from the TV can lower your energy bill and increase your quality time.
April 18, 2016

Medscape – Higher Levels of Vitamin D Linked to Lower Cancer Risk, Again

Higher levels of vitamin D are associated with a reduction in cancer risk of more than a 65%, according to a study published online April 6 in PLOS ONE
April 14, 2016

Oncology Central – Biomarkers for prostate cancer: present challenges and future opportunities

In this review, we examine the current literature evaluating biomarkers in PCa. We also address current limitations and present several ideas for future studies.
April 13, 2016

VA NY Harbor – Feeling Good, Feeling Good

Two weeks after completion of five SBRT treatments, Mr. Quarles says ‘ “I’m feeling good. I’m feeling good. I just have come in for a two week follow up.”
April 12, 2016 – Scientific American article “Choosing The Right Treatment For Prostate Cancer”

" have time to learn all you can about your prostate cancer test results and options, to make the best prostate cancer treatment choices possible for YOU."
April 11, 2016

Urology Times – Placement of a hydrogel rectal spacer before RT for prostate Ca

With increasing scrutiny of the sequelae of prostate cancer therapies, placement of a pretreatment spacer may become increasingly prevalent.
April 11, 2016

Prostate Cancer Foundation – Hormone Therapy for Prostate Cancer Tied to Depression

Older men who receive testosterone-suppressing therapy for prostate cancer may be at increased risk of developing depression.
April 6, 2016

King5 – Cushioning the effects of prostate radiation

When Garret Ihler underwent radiation for his prostate cancer, he was able to skip the usual side effects, thanks to a product called SpaceOAR Hydrogel.
April 5, 2016

FiercePharma – Augmenix touts study of its rectal spacer to cut radiotherapy effects

Waltham, MA's Augmenix touted its FDA-cleared absorbable spacer for improving prostate cancer radiotherapy.
March 30, 2016

MedPage Today – Prostate Cancer: Secondary Cancers More Common With Radiation Tx

A meta-analysis of observational studies suggests a higher risk for bladder, rectal, and colon cancers among prostate...
March 29, 2016

MedScape – Medicare Suspends Penalty-for-PSA-Testing Proposal March 28, 2016

In an online statement, CMS said it will continue to solicit input "to determine whether a restructured, appropriate-use PSA measure should be developed."
March 28, 2016 – Is Early Baldness in Blacks a Clue to Prostate Cancer? March 26, 2016

Black men with early hair loss may have a heightened risk of developing prostate cancer, researchers report.
March 25, 2016

Medscape – Fall in PSA Screening Resulting in More Advanced Disease, March 24, 2016

" recommending uniformly against PSA screening, we may be throwing out the baby with the bathwater," Dr Dalela told Medscape Medical News.
March 24, 2016

Prostate Cancer Foundation – Hospital Volume Tied to Success of Radiation Therapy for Prostate Cancer

Men with aggressive prostate cancer are more likely to survive if they receive radiation therapy at a hospital that provides the treatment to a large number of patients, researchers report.
March 24, 2016

Science Daily – Low vitamin D predicts aggressive prostate cancer

A new study provides a major link between low levels of vitamin D and aggressive prostate cancer.
March 24, 2016

Medical News Today – Prostate cancer targeted with ultrasound ‘could transform treatment’

An ultrasound technique for killing cancer tumors without harming healthy tissue could transform the treatment of prostate cancer.
March 23, 2016

Future of Personal Health – Prostate Health: Why Men Must Be More Vocal

PREVENTION & TREATMENT Men do talk, but their machismo gets in the way of them fully opening up. We can do better, perhaps by using the playbook that women have developed.
March 22, 2016

Business Wire – Florida Cancer Affiliates First in the State Certified to Offer New Spacing Device to Benefit Prostate Cancer Patients

“Providing the best possible treatment to patients is our top priority, which is why we are one of the first centers offering SpaceOAR hydrogel.”
December 16, 2015

TUCC – New Treatment for Prostate Cancer: SpaceOAR Hydrogel

The Urology Center of Colorado is the first site in Denver to offer radiation therapy patients the SpaceOAR hydrogel before their first treatment.
December 9, 2015

The Urology Center of Colorado First in Denver to Offer New Spacing Device to Benefit Prostate Cancer Patients Undergoing Radiation Therapy

The SpaceOAR System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer, creating space to protect the rectum from radiation exposure.